These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15834016)

  • 1. Prognosis in the acute motor axonal form of Guillain-Barré syndrome.
    Gabriel CM
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):622. PubMed ID: 15834016
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
    Yuki N; Miyatake T
    Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies.
    Yu RK; Ariga T; Usuki S; Kaida K
    Adv Exp Med Biol; 2011; 705():349-65. PubMed ID: 21618117
    [No Abstract]   [Full Text] [Related]  

  • 4. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal Guillain-Barré syndrome: concepts and controversies.
    Kuwabara S; Yuki N
    Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?
    Berciano J; Illa I
    Neurology; 2005 Feb; 64(4):766-7; author reply 766-7. PubMed ID: 15728323
    [No Abstract]   [Full Text] [Related]  

  • 7. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice.
    McGonigal R; Rowan EG; Greenshields KN; Halstead SK; Humphreys PD; Rother RP; Furukawa K; Willison HJ
    Brain; 2010 Jul; 133(Pt 7):1944-60. PubMed ID: 20513658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection.
    Rajabally YA; Kass-Hout T; Wilson P; Damian MS
    Eur J Neurol; 2007 Mar; 14(3):e11-2. PubMed ID: 17355531
    [No Abstract]   [Full Text] [Related]  

  • 10. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.
    Griffin JW; Li CY; Macko C; Ho TW; Hsieh ST; Xue P; Wang FA; Cornblath DR; McKhann GM; Asbury AK
    J Neurocytol; 1996 Jan; 25(1):33-51. PubMed ID: 8852937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell response in acute motor axonal neuropathy.
    Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic marker of acute motor axonal neuropathy in childhood.
    Nishimoto Y; Susuki K; Yuki N
    Pediatr Neurol; 2008 Jul; 39(1):67-70. PubMed ID: 18555178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
    Kuwabara S; Nakata M; Sung JY; Mori M; Kato N; Hattori T; Koga M; Yuki N
    J Neurol Sci; 2002 Jul; 199(1-2):89-92. PubMed ID: 12084449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guillain-Barre syndrome and Campylobacter].
    Engberg JH
    Ugeskr Laeger; 2002 Dec; 164(50):5905-8. PubMed ID: 12553106
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
    Tsang RS
    Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré Syndrome.
    Kaida K
    Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Hye JB; Nachamkin I
    Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
    [No Abstract]   [Full Text] [Related]  

  • 19. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.